Galderma’s shares slumped the most in more than a year after US regulators turned down the Swiss dermatology firm’s rival Botox treatment Relfydess.
Source link
Galderma Slumps After FDA Turns Down Botox Rival Relfydess
Why ‘POV Shopping’ Videos Are a Risk for Luxury
Point-of-view videos secretly filmed inside luxury boutiques by content creators wearing smartglasses are going viral on TikTok and Instagram, creating…
Beauty Chases Its New Rocket Ships
As companies lower their forecasts, brace for tariffs and undertake layoffs, the industry is realising its tried-and-true categories and markets…
The Great Sustainability Rebrand | BoF
Shayeza Walid Shayeza Walid is Senior Editorial Associate covering Sustainability at The Business of Fashion. She reports on fashion’s environmental…